BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17064207)

  • 1. Management of antiplatelet therapy for minimization of bleeding risk before cardiac surgery.
    Weant KA; Flynn JF; Akers WS
    Pharmacotherapy; 2006 Nov; 26(11):1616-25. PubMed ID: 17064207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; WilczyƄski M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
    Umman B
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of antiplatelet agents in patients undergoing cardiac surgery.
    Lavi S; Lavi R
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):680-6. PubMed ID: 22534412
    [No Abstract]   [Full Text] [Related]  

  • 9. Scientific and therapeutic advances in antiplatelet therapy.
    Bhatt DL; Topol EJ
    Nat Rev Drug Discov; 2003 Jan; 2(1):15-28. PubMed ID: 12509756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
    Maltais S; Perrault LP; Do QB
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
    Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
    Steinhubl SR
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-directed therapies and coronary artery bypass grafting.
    Berger JS
    Am J Cardiol; 2009 Sep; 104(5 Suppl):44C-8C. PubMed ID: 19695361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism.
    Morawski W; Sanak M; Cisowski M; Szczeklik M; Szczeklik W; Dropinski J; Waclawczyk T; Ulczok R; Bochenek A
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):791-6. PubMed ID: 16153930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy--Part II.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 May; 158(5):506-14. PubMed ID: 8342267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.